Literature DB >> 35381329

RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer.

Wei Li1, Xiaolan Deng1, Jianjun Chen2.   

Abstract

RNA-binding proteins (RBPs) are key players in cellular physiology through posttranscriptional regulation of the expression of target RNA transcripts. By modulating the processing, stability and translation of cancer-related messenger RNA (mRNA) transcripts, a large set of RBPs play essential roles in various types of cancers. Perturbations in RBP activity have been causally associated with cancer development, tumor metabolism, drug resistance, cancer stem cell self-renewal, and tumor immune evasion. Here, we summarize the recent advances in cancer pathological roles and mechanisms of RBPs in regulating mRNA stability and translation with an emphasis on the emerging category of RNA modification-associated RBPs. The functional diversity of RBPs in different types of cancers and the therapeutic potential of targeting dysregulated RBPs for cancer treatment are also discussed.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer development; MRNA stability; MRNA translation; RNA binding proteins; RNA modification

Year:  2022        PMID: 35381329      PMCID: PMC9526761          DOI: 10.1016/j.semcancer.2022.03.025

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   17.012


  1 in total

Review 1.  The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.

Authors:  Shougeng Liu; Sihong Chen; Chengfang Tang; Yingxi Zhao; Wei Cui; Lina Jia; Lihui Wang
Journal:  Front Oncol       Date:  2022-09-26       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.